These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1374519)

  • 41. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
    Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
    J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Testicular amplification and impaired transmission of human butyrylcholinesterase cDNA in transgenic mice.
    Beeri R; Gnatt A; Lapidot-Lifson Y; Ginzberg D; Shani M; Soreq H; Zakut H
    Hum Reprod; 1994 Feb; 9(2):284-92. PubMed ID: 8027285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
    Semba K; Kamata N; Toyoshima K; Yamamoto T
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6497-501. PubMed ID: 2995967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant transformation of a human fibroblast cell strain by transfection of a v-fes oncogene but not by transfection of a gag-human c-fes construct.
    Lin C; Wang Q; Maher VM; McCormick JJ
    Cell Growth Differ; 1994 Dec; 5(12):1381-7. PubMed ID: 7696187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Periodontal disease associated with amegakaryocytic thrombocytopenia in systemic lupus erythematosus.
    Vogel RI
    J Periodontol; 1981 Jan; 52(1):20-3. PubMed ID: 6937647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acetylcholinesterase and butyrylcholinesterase expression in adult rabbit tissues and during development.
    Jbilo O; L'Hermite Y; Talesa V; Toutant JP; Chatonnet A
    Eur J Biochem; 1994 Oct; 225(1):115-24. PubMed ID: 7925428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A polymorphism in human platelet antigen 6b and risk of thrombocytopenia in patients with systemic lupus erythematosus.
    Amengual O; Atsumi T; Komano Y; Kataoka H; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2007 Aug; 56(8):2803-5. PubMed ID: 17665449
    [No Abstract]   [Full Text] [Related]  

  • 49. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombocytopenia and CD34 expression is decoupled from α-granule deficiency with mutation of the first growth factor-independent 1B zinc finger.
    Rabbolini DJ; Morel-Kopp MC; Chen Q; Gabrielli S; Dunlop LC; Chew LP; Blair N; Brighton TA; Singh N; Ng AP; Ward CM; Stevenson WS
    J Thromb Haemost; 2017 Nov; 15(11):2245-2258. PubMed ID: 28880435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-mediated amegakaryocytic thrombocytopenia associated with systemic lupus erythematosus.
    Nagasawa T; Sakurai T; Kashiwagi H; Abe T
    Blood; 1986 Feb; 67(2):479-83. PubMed ID: 3484642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On functions of cholinesterases during embryonic development.
    Paraoanu LE; Steinert G; Klaczinski J; Becker-Röck M; Bytyqi A; Layer PG
    J Mol Neurosci; 2006; 30(1-2):201-4. PubMed ID: 17192676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Counter-regulation of cholinesterases: differential activation of PKC and ERK signaling in retinal cells through BChE knockdown.
    Bodur E; Layer PG
    Biochimie; 2011 Mar; 93(3):469-76. PubMed ID: 21094673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protooncogene expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus as an indicator of the disease activity.
    Deguchi Y; Hara H; Negoro S; Kakunaga T; Kishimoto S
    Clin Immunol Immunopathol; 1987 Dec; 45(3):424-39. PubMed ID: 3677489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of cholinesterases in a young and healthy middle-European population: Relevance for toxicology, pharmacology and clinical praxis.
    Karasova JZ; Maderycova Z; Tumova M; Jun D; Rehacek V; Kuca K; Misik J
    Toxicol Lett; 2017 Aug; 277():24-31. PubMed ID: 28465191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
    Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
    Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of methods used for the determination of cholinesterase activity in whole blood.
    Naik RS; Doctor BP; Saxena A
    Chem Biol Interact; 2008 Sep; 175(1-3):298-302. PubMed ID: 18555980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An identity crisis for fps/fes: oncogene or tumor suppressor?
    Sangrar W; Zirgnibl RA; Gao Y; Muller WJ; Jia Z; Greer PA
    Cancer Res; 2005 May; 65(9):3518-22. PubMed ID: 15867340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Detecting anti-megakaryocyte antibodies in serum of systemic lupus erythematosus patients by indirect immunofluorescence].
    Luo XY; Wu LJ; Chen L; Yang MH; Liu NT; Ku-Er B; Xie CM; Shi RG; Tang Z; Zhao Y; Zeng XF; Yuan GH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):734-7. PubMed ID: 21729561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma.
    Castillo-González AC; Nieto-Cerón S; Pelegrín-Hernández JP; Montenegro MF; Noguera JA; López-Moreno MF; Rodríguez-López JN; Vidal CJ; Hellín-Meseguer D; Cabezas-Herrera J
    BMC Cancer; 2015 May; 15():385. PubMed ID: 25956553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.